ACTA1 and pancreatic neoplasm: Tumor-suppressing functions of CAFs were reported in pancreatic cancer, in which targeting the believed pro-tumor hedgehog signaling pathway in CAFs, or genetic depletion of αSMA+ CAFs from tumors unexpectedly enhanced tumor progression.